Corindus Vascular Robotics Inc (CVRS) Cut to Hold at BidaskClub

Corindus Vascular Robotics Inc (NYSEMKT:CVRS) was downgraded by equities research analysts at BidaskClub from a “buy” rating to a “hold” rating in a research note issued on Monday, July 24th.

CVRS has been the topic of a number of other research reports. B. Riley reissued a “buy” rating and set a $3.00 target price on shares of Corindus Vascular Robotics in a report on Monday, May 15th. ValuEngine cut shares of Corindus Vascular Robotics from a “hold” rating to a “sell” rating in a report on Monday, July 17th. Finally, Zacks Investment Research raised shares of Corindus Vascular Robotics from a “sell” rating to a “hold” rating in a report on Monday, June 26th. Two investment analysts have rated the stock with a sell rating and three have given a buy rating to the stock. Corindus Vascular Robotics currently has an average rating of “Hold” and a consensus target price of $2.67.

Corindus Vascular Robotics (CVRS) opened at 1.48 on Monday. Corindus Vascular Robotics has a 52 week low of $0.40 and a 52 week high of $2.25. The company’s market cap is $277.20 million. The company’s 50-day moving average price is $1.72 and its 200 day moving average price is $1.30.

Corindus Vascular Robotics (NYSEMKT:CVRS) last posted its quarterly earnings results on Tuesday, August 8th. The medical equipment provider reported ($0.04) EPS for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.01. The company had revenue of $2.26 million for the quarter, compared to analysts’ expectations of $3.10 million. Corindus Vascular Robotics had a negative net margin of 1,272.20% and a negative return on equity of 181.63%. On average, analysts anticipate that Corindus Vascular Robotics will post ($0.21) EPS for the current year.

TRADEMARK VIOLATION WARNING: “Corindus Vascular Robotics Inc (CVRS) Cut to Hold at BidaskClub” was first published by BNB Daily and is the sole property of of BNB Daily. If you are viewing this story on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright legislation. The original version of this story can be accessed at https://www.baseball-news-blog.com/2017/08/19/corindus-vascular-robotics-inc-cvrs-rating-lowered-to-hold-at-bidaskclub-updated-updated-updated.html.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. California State Teachers Retirement System raised its position in Corindus Vascular Robotics by 34.4% in the second quarter. California State Teachers Retirement System now owns 148,558 shares of the medical equipment provider’s stock worth $276,000 after buying an additional 38,000 shares during the period. State Street Corp raised its position in Corindus Vascular Robotics by 44.3% in the second quarter. State Street Corp now owns 926,439 shares of the medical equipment provider’s stock worth $1,724,000 after buying an additional 284,507 shares during the period. Goldman Sachs Group Inc. raised its position in Corindus Vascular Robotics by 147.8% in the second quarter. Goldman Sachs Group Inc. now owns 58,824 shares of the medical equipment provider’s stock worth $109,000 after buying an additional 35,086 shares during the period. Vanguard Group Inc. raised its position in Corindus Vascular Robotics by 57.6% in the second quarter. Vanguard Group Inc. now owns 3,279,185 shares of the medical equipment provider’s stock worth $6,100,000 after buying an additional 1,198,384 shares during the period. Finally, Northern Trust Corp raised its position in shares of Corindus Vascular Robotics by 42.4% in the second quarter. Northern Trust Corp now owns 959,920 shares of the medical equipment provider’s stock valued at $1,786,000 after buying an additional 285,811 shares during the period.

About Corindus Vascular Robotics

Corindus Vascular Robotics, Inc is engaged in robotic-assisted vascular interventions. The Company’s CorPath System is a medical device that brings robotic-assisted precision to radial, coronary and peripheral procedures. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries.

Receive News & Ratings for Corindus Vascular Robotics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply